Histogenics Insiders

Histogenics Management Team Effectiveness

The company has return on total asset (ROA) of (1.3646) % which means that it has lost $1.3646 on every $100 spent on assets. This is way below average. Histogenics' management efficiency ratios could be used to measure how well Histogenics manages its routine affairs as well as how well it operates its assets and liabilities. Histogenics has a total of 94.6 Million outstanding shares. Histogenics retains 6.44 (percent) of its outstanding shares held by insiders and 10.94 (percent) owned by outside corporations. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it. Some institutional investors establish a significant position in stocks such as Histogenics in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Histogenics, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.

Histogenics Workforce Comparison

String symbol = request.getParameter("s");

Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

If you are still planning to invest in Histogenics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Histogenics' history and understand the potential risks before investing.